Current Liabilities Cambiamento Data
AbbVie USD 36.4B 2.35B 2025-03
Adma Biologics USD 55.54M 10.65M 2024-12
Amgen USD 23.01B 91M 2025-03
AstraZeneca USD 33.54B 4.41B 2025-06
Biogen USD 3.18B 2.11B 2025-06
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Dynavax Technologies USD 68.38M 10.26M 2025-03
Gilead Sciences USD 12B 279M 2024-12
Glaxosmithkline GBP 21.7B 238M 2024-12
Merck USD 25.17B 3.25B 2025-03
Neurocrine Biosciences USD 546.3M 23.4M 2025-06
Novartis USD 31.71B 95M 2025-06
Pfizer USD 36.45B 6.54B 2025-03
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
TG Therapeutics USD 90.68M 34.43M 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12


Dynavax Technologies Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.